Search

Your search keyword '"I George"' showing total 2,024 results

Search Constraints

Start Over You searched for: Author "I George" Remove constraint Author: "I George"
2,024 results on '"I George"'

Search Results

1. Genetic deletion of calcium-independent phospholipase A2γ protects mice from diabetic nephropathy.

2. Effects of insulin and analogues on carcinogen-induced mammary tumours in high-fat-fed rats

3. Unravelling the Interplay between Competencies, Career Preparedness, and Perceived Employability among Postgraduate Students: A Structural Model Analysis

8. An Overview of Data Security Algorithms in Cloud Computing

9. Curcumin prevents high fat diet induced insulin resistance and obesity via attenuating lipogenesis in liver and inflammatory pathway in adipocytes.

13. Outcomes in children of women with type 2 diabetes exposed to metformin versus placebo during pregnancy (MiTy Kids): a 24-month follow-up of the MiTy randomised controlled trial

16. Genetic deletion of calcium-independent phospholipase A2γ protects mice from diabetic nephropathy.

17. Metformin in women with type 2 diabetes in pregnancy (MiTy): a multicentre, international, randomised, placebo-controlled trial

22. P1049: A PHASE 2 STUDY OF BEZUCLASTINIB (CGT9486), A NOVEL, HIGHLY SELECTIVE, POTENT KIT D816V INHIBITOR, IN ADULTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS (APEX): METHODS, BASELINE DATA, AND EARLY INSIGHTS

29. Outcomes in children of women with type 2 diabetes exposed to metformin versus placebo during pregnancy (MiTy Kids): a 24-month follow-up of the MiTy randomised controlled trial

33. Subclonal KIT D816V Mutations Are Prevalent in Chronic Myelomonocytic Leukemia and Correlate with Distinct Phenotypic Features

36. Proposed refined diagnostic criteria and classification of eosinophil disorders and related syndromes

38. Standards of Genetic Testing in the Diagnosis and Prognostication of Systemic Mastocytosis in 2022: Recommendations of the EU-US Cooperative Group

39. Global Classification of Mast Cell Activation Disorders: An ICD-10-CM–Adjusted Proposal of the ECNM-AIM Consortium

40. Avapritinib Improved Skin Findings In Patients With Indolent Systemic Mastocytosis In the Registrational, Double-Blind, Placebo Controlled PIONEER Study

42. Avapritinib versus Placebo in Indolent Systemic Mastocytosis

46. FIGHT-203, an Ongoing Phase 2 Study of Pemigatinib in Patients With Myeloid/Lymphoid Neoplasms (MLNs) With Fibroblast Growth Factor Receptor 1 (FGFR1) Rearrangement (MLNFGFR1): A Focus on Centrally Reviewed Clinical and Cytogenetic Responses in Previously Treated Patients

48. An Updated Analysis on Safety and Efficacy of Avapritinib in Patients with Advanced Systemic Mastocytosis from the Explorer Clinical Study: Long-Term Efficacy and Safety

49. Synchronous Health Care Delivery for the Optimization of Cardiovascular and Renal Care in Patients with Type 2 Diabetes

Catalog

Books, media, physical & digital resources